x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

science life sciences

All Episodes

55:43

The CEO leading Ensera's evolution

Molecule to Market: Inside the outsourcing space ·

2025/11/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Anderson, Chief Executive Officer at Ensera.Your host, Raman Sehgal, speaks with Jason about the pharmaceutical and biotechnology supply chain, covering: Why he chose BASF over law school, and why McKinsey ultimately was not for him Moving from corporate life into a venture-backed polymer technology start-up before a major exit The search for a PE-backed specialty

en

28:51

CPHI 2025 wrap-up

Molecule to Market: Inside the outsourcing space ·

2025/10/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal, who discusses the themes and vibe of CPHI 2025 in Frankfurt.Molecule to Market is also sponsored by Bora Pharma and Charles River, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a

en

33:56

20 years of CPHI - Veterans Guide

Molecule to Market: Inside the outsourcing space ·

2025/10/24

In this episode of Molecule to Market, you’ll hear wily old wisdom, golden nuggets and invaluable insider tips about CPHI. The nuanced stuff from Veterans of CPHIs gone by you’ll never find in a generic AI-written playbook. The show features:James West, Managing Director, Bourne Partners Arul Ramadurai, CCO at Axplora Christine Fuerst, Director Key Account Management Europe, Vetter Pharma International GmbH Dan Stanton, leading pharma/biopharma industry journalist Jeremy Drummond PhD, retired VP

en

42:27

Themes from PBOA Conference 2025

Molecule to Market: Inside the outsourcing space ·

2025/10/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: How planned FDA budget cuts and the ongoing US government shutdown are impacting the industry. And the potential outlook if those issues remain unresolved... Why positive early-phase clinical trial

en

55:01

The understated CDMO CCO

Molecule to Market: Inside the outsourcing space ·

2025/10/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JB Agnus, Chief Commercial Officer at Bora Pharmaceuticals.Your host, Raman Sehgal, speaks with JB about the pharmaceutical and biotechnology supply chain, including: How his global roles taught him the importance of bridging cultures What attracted him to Bora Pharmaceuticals and the company’s remarkable trajectory The value of intentionality, taking charge of your own career,

en

45:18

The CEO driving change at Curia

Molecule to Market: Inside the outsourcing space ·

2025/10/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Philip Macnabb, Chief Executive Officer at Curia.Your host, Raman Sehgal, speaks with Phil about the pharmaceutical and biotechnology supply chain, covering: Over 25 years of working with private equity — and why PE is ultimately about building sustainable value. The common threads he looks for as a CEO of any new organisation, and why employees often know the answer

en

53:19

The People-first CEO of FUJIFILM Biotechnologies

Molecule to Market: Inside the outsourcing space ·

2025/10/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company to another in Genentech/Roche. How leaving a Biogen site led him to step away from big pharma after

en

58:30

Driving growth and removing waste for big pharma

Molecule to Market: Inside the outsourcing space ·

2025/09/26

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matt Lowe, CEO at performance.io/Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: Seeing a niche in SEO, within the healthcare space... and opting to take a risk and jump our of big pharma. Why healthcare agency models are built for agencies, not pharma. The mass wastage of big pharma spend when it comes to the commercial

en

42:41

Riding the ups and downs of entrepreneurship

Molecule to Market: Inside the outsourcing space ·

2025/09/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: The influences, and potential for impact that led him down a path of entrepreneurship. Chronicling the ups and downs of over 20 years in business at Leukocare. Pivoting to be a specialist CRO/CDMO with a

en

55:11

Unlocking CDMO growth via commercial excellence

Molecule to Market: Inside the outsourcing space ·

2025/09/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Being on the sunny side of consulting, and helping clients unlock growth. What makes a key strategic partnership both from a CDMO, and a sponsor perspective. The taboo subject of pricing and how it

en

53:20

Pharma services market sentiment at the midpoint of 25

Molecule to Market: Inside the outsourcing space ·

2025/09/05

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam's journey from academic to commercial, and what helped him transition into 'life science enablers". How pandemic demand has left our sector with a huge over capacity issue and market imbalance. Some

en

56:07

Doc to CEO - 40 years of reinvention in biopharma

Molecule to Market: Inside the outsourcing space ·

2025/08/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Stephen, covering: His journey of almost 40 years in the industry, including 20 years as a CEO. Leading two therapeutic companies to two, successful, $billion+ exits... Not making snap judgements and instant opinions

en

43:32

Meet the new boss of CPHI Europe

Molecule to Market: Inside the outsourcing space ·

2025/08/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director - Pharma (CPHI Europe).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tara, covering: How CPHI has changed over the last decade of Tara being involved in the show. The challenge of dealing with the volume of over 60k people turning up for three days at a major European city. Being tasked with running one of

en

52:52

30 years on the rollercoaster of clinical trials

Molecule to Market: Inside the outsourcing space ·

2025/08/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Riches, Vice President, Clinical Solutions at Citeline.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: Being involved in the clinical development and commercial launch of a little mega-blockbuster, called... Viagra. Her first exposure to outsourcing at a small biotech, and the importance of partnerships in

en

57:16

The rain-making, 2X exit founder

Molecule to Market: Inside the outsourcing space ·

2025/08/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrea Wagner, CEO at PharmaPhixx.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrea, covering: Building a 'not very pretty' business, to an eventual exit after 10 years The reluctant founding of Berkshire Sterile Manufacturing (Now Sharp)...making new mistakes on her encore journey of growth and a second exit Why company leaders

en

50:47

The Indian CEO driving change

Molecule to Market: Inside the outsourcing space ·

2025/08/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ankit Gupta, CEO at Tenshi Kaizen.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ankit, covering: His accidental journey into pharma, and then pharma manufacturing How his exposure to the pharma value chain via consulting led to numerous roles in the sector, including a critical one at Strides Pharma Sciences Limited and other group

en

57:37

40 years, 6 exits - a CEO addict

Molecule to Market: Inside the outsourcing space ·

2025/07/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Sherlock, CEO at Qinecsa.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: How he developed his professional CEO skills over the years to complement is entrepreneurial spirit The combination of micro and macro factors that help determine when the right time is to go to market, and sell The importance of your gut

en

01:16:29

CDMO Live insights: Industry leaders on the future of...

Molecule to Market: Inside the outsourcing space ·

2025/07/18

In this special episode of Molecule to Market, recorded at this year’s CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by: Gil Roth - PBOA Dr. Jim Li - BioDuro Sundia Kaan-Fabian Kekec - Simon-Kucher They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you’ll hear: How CDMOs are adapting to early-stage funding strain and

en

49:02

The learning curve of a biotech founder/CSO

Molecule to Market: Inside the outsourcing space ·

2025/07/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hella Kohlhof, CSO at Immunic.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hella, covering: How the 'waste of two molecules' led to the spin-out creation of Immunic Therapeutics. The perfect blend of a founding team willing to split responsibility, learn and have a go. Ending up as a Nasdaq-listed company via a reverse merger... and

en

44:52

The cancer Doc, driven by impact

Molecule to Market: Inside the outsourcing space ·

2025/07/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Showalter, Radiation Oncologist, Founder and Chief Medical Officer at ArteraAI.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering: The attraction of radiation oncology at med school and his fascination with clinical trials His frustration with tools for cervical cancer patients led to the creation of a medical device

en

246 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter